Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and Other US Government Payers Perspectives: The ISPOR Drug Cost Task Force Report—Part IV
| Autor: | Mullins, C. Daniel, Seal, Brian, Seoane-Vazquez, Enrique, Sankaranarayanan, Jayashri, Asche, Carl V., Jayadevappa, Ravishankar, Lee, Won Chan, Romanus, Dorothy K., Wang, Junling, Hay, Joel W., Smeeding, Jim |
|---|---|
| Zdroj: | In Value in Health 2010 13(1):18-24 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect